Publications by authors named "M Fontanilles"

Claim this Profile
P
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine).
Roman Vion, Céline Calbrix, Anca Berghian, Emilie Lévêque, Maxime Fontanilles

Clin Transl Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study.
Nicolas Goliot, Emmanuel Jouglar, Julian Jacob, François Christy, Eva Seutin, Maxime Fontanilles

Radiat Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study.
Dinu Stefan, Paul Lesueur, Justine Lequesne, Loic Feuvret, Charlotte Bronnimann, Maxime Fontanilles

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
Séréna Pulcini, Ludivine Beaussire-Trouvay, Florent Marguet, Pierre-Julien Viailly, Olivier Langlois, Maxime Fontanilles

J Neurooncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.
Maxime Fontanilles, Jean-David Heisbourg, Arthur Daban, Frederic Di Fiore, Louis-Ferdinand Pépin

Acta Neuropathol Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis